A family-based approach reveals the function of residues in the nuclear receptor ligand-binding domain

被引:33
作者
Folkertsma, S
van Noort, P
Van Durme, J
Joosten, HJ
Bettler, E
Fleuren, W
Oliveira, L
Horn, F
de Vlieg, J
Vriend, G
机构
[1] Univ Nijmegen, CMBI, NL-6500 GL Nijmegen, Netherlands
[2] Univ Nacl Estadual Sao Paulo, Escola Paulista Med, BR-04041990 Sao Paulo, Brazil
[3] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA
[4] NV Organon, NL-5340 BH Oss, Netherlands
[5] IBCP, F-69367 Lyon, France
关键词
nuclear receptors; entropy-variability plots; mutation data; ligand binding residues; structure-based sequence alignment;
D O I
10.1016/j.jmb.2004.05.075
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Literature studies, 3D structure data, and a series of sequence analysis techniques were combined to reveal important residues in the structure and function of the ligand-binding domain of nuclear hormone receptors. A structure-based multiple sequence alignment allowed for the seamless combination of data from many different studies on different receptors into one single functional model. It was recently shown that a combined analysis of sequence entropy and variability can divide residues in five classes; (1) the main function or active site, (2) support for the main function, (3) signal transduction, (4) modulator or ligand binding and (5) the rest. Mutation data extracted from the literature and intermolecular contacts observed in nuclear receptor structures were analyzed in view of this classification and showed that the main function or active site residues of the nuclear receptor ligand-binding domain are involved in cofactor recruitment. Furthermore, the sequence entropy-variability analysis identified the presence of signal transduction residues that are located between the ligand, cofactor and dimer sites, suggesting communication between these regulatory binding sites. Experimental and computational results agreed well for most residues for which mutation data and intermolecular contact data were available. This allows us to predict the role of the residues for which no functional data is available yet. This study illustrates the power of family-based approaches towards the analysis of protein function, and it points out the problems and possibilities presented by the massive amounts of data that are becoming available in the "omics era". The results shed light on the nuclear receptor family that is involved in processes ranging from cancer to infertility, and that is one of the more important targets in the pharmaceutical industry. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:321 / 335
页数:15
相关论文
共 78 条
[1]   Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1α with multiple steroid receptors and identification of an internally deleted ELE1β isoform [J].
Alen, P ;
Claessens, F ;
Schoenmakers, E ;
Swinnen, JV ;
Verhoeven, G ;
Rombauts, W ;
Peeters, B .
MOLECULAR ENDOCRINOLOGY, 1999, 13 (01) :117-128
[2]  
Auwerx J, 1999, CELL, V97, P161
[3]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[4]   Structural adaptability in the ligand-binding pocket of the ecdysone hormone receptor [J].
Billas, IML ;
Iwema, T ;
Garnier, JM ;
Mitschler, A ;
Rochel, N ;
Moras, D .
NATURE, 2003, 426 (6962) :91-96
[5]   The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003 [J].
Boeckmann, B ;
Bairoch, A ;
Apweiler, R ;
Blatter, MC ;
Estreicher, A ;
Gasteiger, E ;
Martin, MJ ;
Michoud, K ;
O'Donovan, C ;
Phan, I ;
Pilbout, S ;
Schneider, M .
NUCLEIC ACIDS RESEARCH, 2003, 31 (01) :365-370
[6]   Estrogen receptor-related receptor impinges on the estrogen axis in bone: Potential function in osteoporosis [J].
Bonnelye, E ;
Kung, V ;
Laplace, C ;
Galson, DL ;
Aubin, JE .
ENDOCRINOLOGY, 2002, 143 (09) :3658-3670
[7]  
Bork P, 1996, METHOD ENZYMOL, V266, P162
[8]   Nuclear receptor ligand-binding domains three-dimensional structures, molecular interactions and pharmacological implications [J].
Bourguet, W ;
Germain, P ;
Gronemeyer, H .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (10) :381-388
[9]   Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains [J].
Bourguet, W ;
Vivat, V ;
Wurtz, JM ;
Chambon, P ;
Gronemeyer, H ;
Moras, D .
MOLECULAR CELL, 2000, 5 (02) :289-298
[10]   CRYSTAL-STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA [J].
BOURGUET, W ;
RUFF, M ;
CHAMBON, P ;
GRONEMEYER, H ;
MORAS, D .
NATURE, 1995, 375 (6530) :377-382